Dr. Mikael Palner, an associate professor at the University of Southern Denmark, researches the effects of psilocybin microdosing on maladaptive neuropsychiatric diseases. He discusses how microdosing may enhance stress resiliency and reduce compulsive behaviors, highlighting intriguing disparities between rat and human studies. Palner emphasizes the need for caution regarding microdosing practices and the misconception that it universally boosts cognitive performance. He also explores the biological mechanisms behind psilocybin's effects, advocating for further nuanced research.